NAOV: NanoVibronix, Inc. Stock

by  •  • Comments Off on NAOV: NanoVibronix, Inc. Stock

SIC 3842 – Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Valuation
Market Cap ($M) 3.61
Enterprise Value ($M) 2.85
Book Value ($M) 0.63
Book Value / Share 0.83
Price / Book 5.75
NCAV ($M) 0.33
NCAV / Share 0.43
Price / NCAV 10.96

Profitability (mra)
Return on Invested Capital (ROIC) -4.99
Return on Assets (ROA) -0.59
Return on Equity (ROE) -1.06

Liquidity (mrq)
Quick Ratio 0.42
Current Ratio 1.22

Balance Sheet (mrq) ($M)
Current Assets 3.33
Assets 3.63
Liabilities 3.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.56
Operating Income -3.58
Net Income -3.71
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.52
Cash from Investing -0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 13.91

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 34,994 110,990 31.53
2025-04-28 16,861 45,955 36.69
2025-04-25 30,431 121,317 25.08
2025-04-24 10,374 45,650 22.73

(click for more detail)

Similar Companies
MGRM – Monogram Technologies Inc. MODD – Modular Medical, Inc.
MOVE – Movano Inc. NDRA – ENDRA Life Sciences Inc.
NEPH – Nephros, Inc.


Financial data and stock pages provided by
Fintel.io